Opportunity Information: Apply for RFA DA 16 003
Apply for RFA DA 16 003
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Tools and Services for Designing Methodologically Rigorous Animal Studies (R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Jun 4, 2015 and posted on Jun 4, 2015.
- Applicants must submit their applications by Aug 5, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,300,000.00 to eligible and selected applicants.
- Eligible applicants include: Small businesses.
- Other Eligible Applicants include the following Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Tools and Services for Designing Methodologically Rigorous Animal Studies (R43/R44) is a National Institutes of Health (NIH) small business funding opportunity focused on improving the quality and reliability of in vivo animal research by supporting the creation of practical tools and services that help scientists design more methodologically rigorous animal experiments. The central purpose of the announcement is not to fund animal studies themselves as the main product, but to encourage small businesses to research and develop enabling resources that make it easier for life science investigators to plan animal experiments correctly from the start, with attention to issues that commonly undermine rigor, reproducibility, and interpretability. In plain terms, NIH is looking for solutions that guide researchers toward stronger experimental design choices in animal work so that results are more trustworthy and less likely to be biased or irreproducible.
This opportunity is offered as an SBIR/STTR-style phased program using the R43/R44 grant mechanisms, which generally map to early-stage feasibility work followed by more advanced development. Phase I (R43) typically supports proof-of-concept and technical feasibility, while Phase II (R44) generally supports further development, refinement, testing, and steps that move a product or service toward real-world use by researchers. The projects supported under this FOA are expected to have a clear development trajectory consistent with building a usable research tool or service rather than producing only academic findings.
The kinds of supported outputs could include software, decision-support systems, online platforms, structured workflows, or specialized consulting or methodological services that help investigators incorporate key elements of rigorous animal study design. While the announcement text provided here does not enumerate specific design elements, the phrase "methodological rigor" in animal experiments commonly points to practices such as appropriate randomization, blinding, sample size and power considerations, prespecified inclusion/exclusion criteria, handling of attrition, transparent reporting, reduction of bias, and ensuring that study endpoints and analysis plans are appropriate and clearly defined. A competitive project under this theme would usually show how the proposed tool or service would actually change researcher behavior or improve study planning in a measurable way, for example by embedding checklists, guided design wizards, automated calculations, protocol templates, or audit-ready documentation that aligns with widely accepted standards for rigorous preclinical research.
Administratively, this is a discretionary grant opportunity in the NIH health and education research domain, tied to the CFDA program number 93.279 (Drug Abuse and Addiction Research Programs), indicating that the issuing NIH Institute/Center is aligned with substance use and addiction research priorities. Even so, the need for rigor-enhancing animal study design tools is broadly relevant across the life sciences, and applicants would typically be expected to explain how their product or service would be applicable to NIH-funded preclinical research, including areas relevant to drug abuse and addiction.
Eligibility is restricted to U.S. small business concerns, consistent with the SBIR/STTR framework. Non-U.S. (foreign) institutions are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible. However, the announcement notes that foreign components, as NIH defines them in the NIH Grants Policy Statement, may be allowed in some circumstances, which usually means limited, well-justified parts of the work can be performed outside the U.S. when there is a strong scientific or practical reason and it is permitted under NIH policy.
The FOA does not require cost sharing or matching, which can make it more accessible for small businesses that are early in development or do not have large pools of non-federal capital to commit. The estimated total funding amount listed for this opportunity is $1.3 million, suggesting a relatively targeted solicitation intended to seed a modest number of projects that can produce tangible, deployable tools or services. The opportunity was posted on June 4, 2015, with an original and current closing date of August 5, 2015, and it was archived on September 5, 2015, meaning it was a time-limited solicitation and is no longer open under that specific announcement number.
For applicants, the practical takeaway is that NIH sought small business-led R&D aimed at improving the front-end design of animal experiments through products or services that operationalize best practices in rigor. A strong proposal under this kind of FOA would usually define the user (for example, academic investigators, industry preclinical teams, CROs, IACUC-facing research groups, or core facilities), specify the exact problem in current animal study planning that the tool or service solves, describe the technical approach and development milestones for Phase I and Phase II, and show a plausible path to adoption in real research settings. The full archived announcement and application instructions were available via the NIH grants guide page associated with RFA-DA-16-003, and NIH provided standard technical contact support through the NIH Office of Extramural Research webmaster for access or linking issues.
Frequently Asked Questions (FAQs)
What is the purpose of the "Tools and Services for Designing Methodologically Rigorous Animal Studies (R43/R44)" opportunity?
This NIH small business funding opportunity is focused on improving the quality, reliability, and interpretability of in vivo animal research by supporting the creation of practical tools and services that help scientists design more methodologically rigorous animal experiments.
Is NIH funding animal studies themselves under this announcement?
No. The central purpose is not to fund animal studies as the main product. The emphasis is on small business R&D that produces enabling tools or services that make it easier for investigators to plan animal experiments correctly from the start.
What kind of work is NIH trying to support with this FOA?
NIH is seeking solutions that guide researchers toward stronger experimental design choices in animal work so results are more trustworthy and less likely to be biased or irreproducible. Projects should have a clear development trajectory toward a usable tool or service rather than producing only academic findings.
What grant mechanisms are used in this opportunity?
The opportunity uses the NIH small business phased program structure with R43/R44 mechanisms, which generally map to early-stage feasibility work followed by more advanced development.
How do Phase I (R43) and Phase II (R44) typically differ for this opportunity?
Phase I (R43) typically supports proof-of-concept and technical feasibility. Phase II (R44) generally supports further development, refinement, testing, and steps that move a product or service toward real-world use by researchers.
What kinds of outputs are encouraged under this FOA?
Supported outputs could include software, decision-support systems, online platforms, structured workflows, or specialized consulting or methodological services that help investigators incorporate key elements of rigorous animal study design.
What does "methodological rigor" in animal experiments generally refer to in this context?
While the provided text does not list required elements, methodological rigor in animal experiments commonly includes appropriate randomization, blinding, sample size and power considerations, prespecified inclusion/exclusion criteria, handling of attrition, transparent reporting, reduction of bias, and clearly defined endpoints and analysis plans.
What would make a project competitive under this theme?
A competitive project would typically show how the tool or service would change researcher behavior or improve study planning in a measurable way, such as embedding checklists, guided design wizards, automated calculations, protocol templates, or audit-ready documentation aligned with widely accepted standards for rigorous preclinical research.
Does this funding opportunity relate to a specific NIH program area?
Administratively, it is tied to CFDA program number 93.279 (Drug Abuse and Addiction Research Programs), indicating alignment with substance use and addiction research priorities. However, the need for rigor-enhancing animal study design tools is broadly relevant across the life sciences, and applicants would typically explain relevance to NIH-funded preclinical research, including areas related to drug abuse and addiction.
Who is eligible to apply?
Eligibility is restricted to U.S. small business concerns, consistent with the SBIR/STTR framework.
Are foreign (non-U.S.) organizations eligible to apply?
No. Non-U.S. (foreign) institutions are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible under this announcement.
Are any foreign components allowed in a project?
The announcement notes that foreign components (as defined by NIH in the NIH Grants Policy Statement) may be allowed in some circumstances. This generally implies limited, well-justified work may be performed outside the U.S. when there is a strong scientific or practical reason and it is permitted under NIH policy.
Is cost sharing or matching required?
No. The FOA does not require cost sharing or matching.
How much funding was estimated for this opportunity?
The estimated total funding amount listed is $1.3 million, suggesting a relatively targeted solicitation intended to seed a modest number of projects that can produce tangible, deployable tools or services.
When was this opportunity posted, and is it still open?
It was posted on June 4, 2015, with an original and current closing date of August 5, 2015. It was archived on September 5, 2015, meaning it is no longer open under that specific announcement.
What is the announcement number associated with the archived FOA?
The archived announcement and application instructions were available via the NIH grants guide page associated with RFA-DA-16-003.
Who are the intended users of tools/services developed under this FOA?
The opportunity suggests that applicants should define the user base. Examples mentioned include academic investigators, industry preclinical teams, CROs, IACUC-facing research groups, and core facilities.
What should an applicant typically explain in a strong proposal for this FOA?
A strong proposal would usually specify the target user, define the specific problem in current animal study planning, describe the technical approach and development milestones for Phase I and Phase II, and present a plausible path to adoption in real research settings.
Where could applicants find the full instructions and archived materials?
The full archived announcement and application instructions were available through the NIH grants guide page for RFA-DA-16-003.
What support was mentioned for technical access or linking issues?
NIH provided standard technical contact support through the NIH Office of Extramural Research webmaster for access or linking issues.
Browse more opportunities from the same category: Education Health
Next opportunity: Behavioral Epigenomics of Aging in Twin Studies (U24)
Previous opportunity: Accreditation of Mexican Law Enforcement Agencies, Emergency Communications Centers and Police Academies to International Standards
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 16 003
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 16 003) also looked into and applied for these:
| Funding Opportunity |
|---|
| Career Development Program in Emergency Care Research (K12) Apply for RFA HL 16 019 Funding Number: RFA HL 16 019 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Harnessing Big Data to Halt HIV (R01) Apply for PA 15 273 Funding Number: PA 15 273 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Smoking Cessation within the Context of Lung Cancer Screening (R01) Apply for RFA CA 15 011 Funding Number: RFA CA 15 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Ethical Issues in Research on HIV/AIDS and its Co Morbidities (R01) Apply for PAR 15 274 Funding Number: PAR 15 274 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Ethical Issues in Research on HIV/AIDS and its Co Morbidities (R21) Apply for PAR 15 275 Funding Number: PAR 15 275 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Turkey US Collaborative Program for Affordable Medical Technologies (R01) Apply for PAR 15 276 Funding Number: PAR 15 276 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Multidisciplinary Studies of HIV/AIDS and Aging (R01) Apply for PAR 15 280 Funding Number: PAR 15 280 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Multidisciplinary Studies of HIV/AIDS and Aging (R03) Apply for PAR 15 281 Funding Number: PAR 15 281 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Multidisciplinary Studies of HIV/AIDS and Aging (R21) Apply for PAR 15 282 Funding Number: PAR 15 282 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Extracellular Vesicles and Substance Abuse (R21) Apply for PAR 15 284 Funding Number: PAR 15 284 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Extracellular Vesicles and Substance Abuse (R01) Apply for PAR 15 283 Funding Number: PAR 15 283 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| The Pancreatic Cancer Detection Consortium (U01) Apply for PAR 15 289 Funding Number: PAR 15 289 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) Apply for PAR 15 297 Funding Number: PAR 15 297 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R43/R44) Apply for RFA DA 16 005 Funding Number: RFA DA 16 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R41/R42) Apply for RFA DA 16 006 Funding Number: RFA DA 16 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Supplements to Support Evaluation of the NCI Cancer Genomics Cloud Pilots (Admin Supp) Apply for PA 15 305 Funding Number: PA 15 305 Agency: National Institutes of Health Category: Education Health Funding Amount: $40,000 |
| Physical Activity and Weight Control Interventions Among Cancer Survivors Effects on Biomarkers of Prognosis and Survival (R01) Apply for PA 15 311 Funding Number: PA 15 311 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Physical Activity and Weight Control Interventions Among Cancer Survivors Effects on Biomarkers of Prognosis and Survival (R21) Apply for PA 15 310 Funding Number: PA 15 310 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Imaging Science Track Award for Research Transition (I/START) (R03) Apply for PAR 15 326 Funding Number: PAR 15 326 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP1) Apply for RFA DA 16 007 Funding Number: RFA DA 16 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 16 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.